Fascial space | HIV + ve n (%) | HIV-ve n (%) | Female n (%) | Male n (%) | Outpatient n (%) | Inpatient n (%) |
---|---|---|---|---|---|---|
Buccal | 14 (6.8) | 38 (18.5) | 28 (13.7) | 24 (11.7) | 47 (22.9) | 5 (2.4) |
Submasseteric | 9 (4.4) | 37 (18.1) | 14 (6.8) | 32 (15.6) | 38 (18.5) | 8 (3.9) |
Submandibular | 14 (6.8) | 22 (10.7) | 18 (8.9) | 18 (8.9) | 21 (10.2) | 15 (7.3) |
Temporal | 4 (2.0) | 11 (5.4) | 6 (2.9) | 9 (4.4) | 10 (4.9) | 5 (2.4) |
Canine | 4 (2.0) | 9 (4.4) | 5 (2.4) | 8 (3.9) | 12 (5.9) | 1 (0.5) |
Parapharyngeal | 5 (2.4) | 7 (3.4) | 5 (2.4) | 7 (3.4) | 3 (1.5) | 9 (4.4) |
Pretracheal | 2 (1.0) | 4 (2.0) | 4 (2.0) | 2 (1.0) | 0 (0.0) | 6 (2.9) |
Peritonsillar | 0 (0.0) | 5 (2.4) | 3 (1.5) | 2 (1.0) | 4 (2.0) | 1 (0.5) |
Pterygoid | 1 (0.5) | 4 (2.0) | 2 (1.0) | 3 (1.5) | 3 (1.5) | 2 (1.0) |
Parotid | 1 (0.5) | 3 (1.5) | 4 (2.0) | 0 (0.0) | 3 (1.5) | 1 (0.5) |
Submental | 0 (0.0) | 3 (1.5) | 2 (1.0) | 1 (0.5) | 3 (1.5) | 0 (0.0) |
Sublingual | 1 (0.5) | 1 (0.5) | 0 (0.0) | 2 (1.0) | 0 (0.0) | 2 (1.0) |
Retropharyngeal | 1 (0.5) | 1 (0.5) | 1 (0.5) | 1 (0.5) | 0 (0.0) | 2 (1.0) |
Labial | 2 (1.0) | 0 (0.0) | 2 (1.0) | 0 (0.0) | 2 (1.0) | 0 (0.0) |
Periorbital | 0 (0.0) | 2 (1.0) | 0 (0.0) | 2 (1.0) | 2 (1.0) | 0 (0.0) |
Single | 18 (14.4) | 50 (40.0) | 39 (31.2) | 29 (23.2) | 61 (48.8) | 7 (5.6) |
Multiple | 16 (12.8) | 41 (32.8) | 22 (17.6) | 35 (28.0) | 40 (32.0) | 17 (13.6) |